4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-062612
Chief Financial Officer sold 30,000 shares at an average $51.24 ($1,537,238)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-08 | Exercise or conversion : show line 1 in the form | +30,000 | $6.32 | $189,600 | 31,000 | D |
| 2020-12-08 | Sale : show line 2 in the form | −20,256 | $50.88 | $1,030,625 | 10,744 | D |
| 2020-12-08 | Sale : show line 3 in the form | −9,444 | $51.98 | $490,899 | 1,300 | D |
| 2020-12-08 | Sale : show line 4 in the form | −300 | $52.38 | $15,714 | 1,000 | D |
| Open-market sales · 30,000 sh · avg $51.24 · $1,537,238 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-08 | Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) | −30,000 | 490,000 | D |
Loading xslF345X03/doc4.xml…